FindTrial
Sign In

Prolongation of duration of Spinal Anaesthesia

Comparison of incremental doses of Buprenorphine as an adjuvant to 0.5% Bupivacaine in lower abdominal and lower limb surgeries done under Subarachnoid Block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024692
Enrollment
90
Registered
2020-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Comparison of incremental doses of Buprenorphine as an adjuvant to 0.5% Bupivacaine in lower abdominal and lower limb surgeries done under subarachnoid block: Patients will be randomly

Sponsors

Dr PSIMS RF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anaesthesiologists grade 1 and 2 patients Patient willing to give consent

Exclusion criteria

Exclusion criteria: Patients allergic to any anesthetic drug Bleeding disorders ASA grade 3 and 4 Patient not willing for consent and follow up

Design outcomes

Primary

MeasureTime frame
Prolonged Post Operative AnalgesiaTimepoint: 24 hours—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactModa Sree Rekha

Dr Pinnamaneni Siddartha Institute of Medical Sciences

drshankar1811974@gmail.com7702028888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026